Theragen Etex Co.Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: 0.020x

Theragen Etex Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.08 Billion ≈ $2.09 Million USD) by net assets (₩152.04 Billion ≈ $103.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Theragen Etex Co.Ltd (2008–2025)

Cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2025. This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 066700 share price today for real-time trading data and today's change.

Theragen Etex Co.Ltd Cash Flow Conversion Ratio Explained

Theragen Etex Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency. Also see 066700 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
RTG Mining Inc AU:RTG	-0.134x
BrilliA Inc NYSE MKT:BRIA	N/A
Unitron Tech Co Ltd KQ:142210	-0.716x
Polychem Indonesia Tbk JK:ADMG	-0.015x
Seafresh Industry Public Company Limited BK:CFRESH	0.070x
Hunan Tyen Machinery Co Ltd B SHG:900946	0.007x
NOCTILUCA S.A. ZY -15 F:G0Z	-0.220x
Sugentech Inc KQ:253840	-0.064x

Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2025. Review how much free cash does Theragen Etex Co.Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.17 Billion ≈ $107.87 Million	₩10.97 Billion ≈ $7.44 Million	0.069x	+403.28%
2024-12-31	₩130.54 Billion ≈ $88.47 Million	₩1.79 Billion ≈ $1.21 Million	0.014x	-82.72%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	₩12.12 Billion ≈ $8.22 Million	0.079x	+18.67%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	₩9.59 Billion ≈ $6.50 Million	0.067x	+271.32%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	₩4.01 Billion ≈ $2.72 Million	0.018x	-49.11%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	₩13.23 Billion ≈ $8.96 Million	0.035x	+12645.45%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	₩37.69 Million ≈ $25.54K	0.000x	+100.12%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	₩-18.58 Billion ≈ $-12.59 Million	-0.230x	-1223.09%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	₩1.78 Billion ≈ $1.20 Million	0.020x	+117.59%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.116x	-1825.75%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	₩-415.37 Million ≈ $-281.49K	-0.006x	-1338.61%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	₩39.95 Million ≈ $27.08K	0.000x	-99.59%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	₩3.14 Billion ≈ $2.13 Million	0.120x	--

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$40.75 Million

₩60.13 Billion KRW

Market Cap Rank

#22450 Global

#1439 in Korea

Share Price

₩1973.00

Change (1 day)

-0.95%

52-Week Range

₩1888.00 - ₩3315.00

All Time High

₩21800.00